By Sierra Jackson ( February 10, 2021, 5:15 PM EST) -- BlackRock-backed genomic and clinical data platform Sema4 announced plans Wednesday to go public through a merger with a blank-check company, in a deal steered by Fenwick & West and White & Case that values Sema4 at roughly $2 billion, including debt and cash on hand....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.